Solid biosciences to present at the 41st annual j.p. morgan healthcare conference

Cambridge, mass., jan. 09, 2023 (globe newswire) -- solid biosciences inc. (nasdaq: sldb), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that bo cumbo, president and chief executive officer, will present at the 41st annual j.p. morgan healthcare conference on thursday, january 12, 2023, at 9:00 am pt / 12:00 pm et.
SLDB Ratings Summary
SLDB Quant Ranking